876 — Kaisa Health group Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$110.93m
- -HK$45.40m
- HK$185.88m
C2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -363 | -41.5 | 11.2 | -171 | 6.05 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 340 | 12.9 | -76.9 | 111 | -44.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.544 | -22.2 | -83.3 | -29.8 | -15.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.82 | -31 | -123 | -58.6 | -35.8 |
Capital Expenditures | -15 | -29.5 | -38.3 | -13.4 | -10.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 63.1 | 9.54 | 167 | 18.8 | 58.1 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 48.2 | -19.9 | 129 | 5.42 | 47.2 |
Financing Cash Flow Items | 1.49 | 0.779 | 93.3 | -12.3 | -1.49 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.04 | -6.47 | 83.4 | -19.4 | -8.83 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 35.4 | -53.6 | 82.7 | -85.8 | 0.628 |